CHICAGO — New research shows a sharp escalation in the weapons race against cancer, with several high-tech approaches long dreamed of but not possible or successful until now.
WASHINGTON — Dermatologists will soon get some high-tech help deciding which suspicious-looking moles should be removed and checked for melanoma, the deadliest form of skin cancer. The Food and Drug Administration on Wednesday approved a first-of-its-kind device, called MelaFind, that makes detailed, digital images of skin growths and uses a computer to analyze them for signs of cancer, offering a sort of second opinion to doctors. The device is approved only for dermatologists and only for use on growths that don’t have obvious signs of cancer but still have one or two worrisome traits.
WASHINGTON — If you’ve hit the beach, chances are you’ve experienced an unfortunate rite of summer: The sunburn. Skin so swollen it hurts to bend. The heat that rises from reddened shoulders. The “ow, ow, ow” from the shower after you’d thought the pain had faded.